Australian anaesthetists urge patients to disclose GLP-1s or gym peptides before surgery. The UK study of 47,000 patients says the link isn't necessarily causal.
Recap by typeshit. Full story at ABC News & Headlines – Australian Broadcasting Corporation.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A look at ATTAIN-1 and ATTAIN-2 found similar results before, during and after menopause, with waists shrinking by up to 12.5 cm over 72 weeks.
At 52 weeks, Lilly reports 1.5% more weight loss on 17.2 mg Foundayo, but the data compares two separate trials rather than a head-to-head study.
Loading…